Overdose Prevention Centers and Behavioral Health
ConditionOverdose
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU, and; (Aim 3) Assess the barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
are 18 years of age or older;
engaged in syringe service program and/or overdose prevention center services in New York City in the past 30 days before the date of enrollment;
are able to complete assessments in English or Spanish;
are competent to give written informed consent at the time of the interview;
Disqualifiers
None
Trial population
Aims 1 and 2 of this study will use secondary analysis of an existing de-identified, linked data set curated as part of an ongoing evaluation of the NYC overdose prevention centers. This dataset will include a total of 500 participants linked to NYC administrative health records. This de-identified data source will be accessed through the NYULH Center for Opioid Epidemiology and Policy (COEP). Should it be deemed necessary, a data use agreement will be established between the PI and NYULH/COEP to facilitate access to these de-identified data. Aim 3 of this study will recruit 30 individuals over age 18 who are currently employed by harm reduction programs for a one-time, qualitative interview.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 2 trial groupsGroup A: Aim 1 & 2 - Dataset
Group B: Aim 3 - Harm Reduction Staff
Trial outcomes
Primary outcomes
1
Incidence of Fatal Overdose
Incidence of fatal overdose will be derived from overdose mortality data from the NYC Office of the Chief Medical Examiner.
Time frame
Up to Month 122
Incidence of Non-Fatal Overdose
Incidence of nonfatal overdose will be assessed using hospitalization and emergency department data from the NYC Regional Health Information Exchange (RHIO) and Statewide Research and Planning Cooperative System (SPARCS).
Time frame
Up to Month 123
Incidence of Psychiatric Services Utilization
Psychiatric services utilization will be assessed from SPARCS, RHIO, and NYS Medicaid.
Time frame
Up to Month 12Sponsors and contacts
Click on the lead sponsor to view all of their trials.
NYU Langone Health
Lead sponsor
Centers for Disease Control and Prevention
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: